4//SEC Filing
Doebele Robert 4
Accession 0000899243-22-014886
CIK 0001724979other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 4:30 PM ET
Size
6.9 KB
Accession
0000899243-22-014886
Insider Transaction Report
Form 4
Doebele Robert
EVP, Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-04-13−3,000→ 8,890 totalExercise: $3.95Exp: 2029-03-13→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2022-04-13$3.95/sh+3,000$11,850→ 472,937 total
Footnotes (1)
- [F1]This option represents a right to purchase a total of 13,890 shares of Issuer's common stock, which is vested in full.
Documents
Issuer
Rain Therapeutics Inc.
CIK 0001724979
Entity typeother
Related Parties
1- filerCIK 0001856681
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 4:30 PM ET
- Size
- 6.9 KB